Session Type
Meeting
Search Results for Transfusion
Abstract Number: 43
SHM Converge 2023
Background: Anemia is a risk factor for cognitive impairment as a result of the reduced delivery of oxygen to the brain from low hemoglobin (Hb) levels. In ambulatory patients even mild anemia (Hb < 12g/dL) has been associated with reductions in patients’ cognitive function. However, in hospitalized patients it is standard of care to maintain […]
Abstract Number: 67
SHM Converge 2021
Background: In hospitalized patients with anemia, the AABB recommends that transfusion of red blood cells occur when a patient’s hemoglobin (Hb) drops below a restrictive transfusion threshold, either at 7 or 8g/dL1. These transfusion guidelines are the result of a growing body of clinical trial evidence showing that transfusion at lower or restrictive Hb thresholds […]
Abstract Number: 90
SHM Converge 2021
Background: Patients with COVID-19 have increased rates of venous thromboembolism, however, there is currently no standardized approach to anticoagulation (AC) therapy particularly with respect to the proper dose of anticoagulation (prophylactic or therapeutic). Many observational studies have shown a mortality benefit in using prophylactic AC for hospitalized patients with COVID-19. A few studies have reported […]
Abstract Number: 90
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Sickle cell disease (SCD) affects about 100,000 people in the US. The disease causes significant mortality, morbidity and frequent hospitalizations secondary to primary manifestations of the disease and its complications. We conducted a retrospective, single institution study in adult patients (pts), ≥ 18 years with SCD to assess factors associated with health care utilization […]
Abstract Number: 98
SHM Converge 2024
Background: The 2016 and 2023 AABB international red blood cell (RBC) transfusion guidelines recommend, in addition to restrictive transfusion practices, that clinicians also consider the patient’s overall clinical context when making transfusion decisions (1). However, there is little empiric data on which specific clinical factors, other than Hb, should inform transfusion decisions in hospitalized patients […]
Abstract Number: 101
SHM Converge 2021
Background: In hospitalized patients with anemia the AABB recommends that transfusion of red blood cells occur when a patient’s hemoglobin (Hb) drops below a restrictive transfusion threshold, either at 7 or 8g/dL. These recommendations are the result of a growing body of clinical trial evidence showing that transfusion at estrictive Hb thresholds is safe, compared […]
Abstract Number: 102
SHM Converge 2021
Background: The World Health Organization defines anemia in females as a hemoglobin (Hb)
Abstract Number: 104
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: We previously found that red blood cell (RBC) transfusion was a trigger for hospitalization for venous thromboembolism (VTE) in a Medicare population. As peripherally inserted central catheters (PICCs) are both associated with VTE and often used for RBC transfusion, we assessed the prevalence of VTE in patients with PICCs. Methods: We used data from […]
Abstract Number: 115
SHM Converge 2023
Background: Anemia is an acute and/or chronic condition with a range of underlying etiologies present in an estimated 40-70% of hospitalized patients. While comprehensive diagnostic and treatment algorithms for anemia exist, they are rarely used by hospitalist clinicians in the inpatient setting. This is because these algorithms were derived in ambulatory patients where acute anemia […]
Abstract Number: 119
Hospital Medicine 2020, Virtual Competition
Background: Anemia is a risk factor for cognitive impairment as a result of reduced delivery of oxygen to the brain from low hemoglobin (Hb) levels. In ambulatory patients, mild anemia (Hb 10-12g/dL) has been associated with reductions in patients’ cognitive function [1–3]. In hospitalized patients it is standard of care to maintain Hb levels far […]